Suppr超能文献

经口激光微创手术治疗鳞状细胞癌后患者的喉部复发部位。

Laryngeal recurrence sites in patients previously treated with transoral laser microsurgery for squamous cell carcinoma.

机构信息

Department of Surgery, Division of Otolaryngology-Head and Neck Surgery, Queen Elizabeth II Health Science Centre and Dalhousie University, 3rd Floor Dickson Building, VG Site, 5820 University Avenue, Halifax, NS, B3H 2Y9, Canada.

Department of Pathology, Division of Anatomical Pathology, Queen Elizabeth II Health Science Centre and Dalhousie University, Halifax, NS, Canada.

出版信息

J Otolaryngol Head Neck Surg. 2018 Feb 13;47(1):14. doi: 10.1186/s40463-018-0266-y.

Abstract

BACKGROUND

The laryngeal framework provides a natural barrier preventing tumour spread to extralaryngeal structures. Transoral laser microsurgery (TLM) for laryngeal squamous cell carcinoma (SCC) may violate these boundaries, altering the pathways of tumor spread for potential recurrences. Our project objective is to describe laryngeal SCC recurrence patterns and overall survival in patients requiring total laryngectomy (TL) after TLM.

METHODS

Patients undergoing TLM for laryngeal SCC requiring salvage TL were identified from a prospective CO2 laser database containing all patients undergoing TLM for head and neck malignancies at the QEII Health Sciences Center in Halifax, Nova Scotia between March 2002 - May 2014. Surgical pathology reports were analyzed for tumor characteristics, extent of recurrence and invasion of local structures. Kaplan-Meier analyses were performed to evaluate overall survival, disease specific survival (DSS) and locoregional control.

RESULTS

Fifteen patients were identified from the database as receiving salvage TL for recurrent disease after initial TLM resection for laryngeal SCC. Final pathology reports demonstrated that 67% (10/15) of patients had thyroid cartilage involvement while 53% (9/15) of patients had cricoid cartilage involvement on salvage TL pathology. 33% (5/15) of patients had perineural invasion and 27% (4/15) had lymphovascular invasion. Mean and median follow-up times were 36.7 months and 26.8 months respectively (range 3.9-112.6). The Kaplan-Meier estimate for overall survival at 36 months was 40% post TL with a standard error (SE) of 13.6%. DSS was 47% (SE 14.2%), and locoregional control was 55% (SE 14.5%) post TL.

CONCLUSIONS

Laryngeal recurrence sites following TLM seem to be consistent with historical data at known laryngeal sites of vulnerability. Treatment with TLM does not predispose patients to a lower rate of locoregional control and overall survival after total laryngectomy and salvage outcomes are consistent with literature values.

摘要

背景

喉框架结构提供了天然屏障,防止肿瘤向喉外结构扩散。经口激光微创手术(TLM)治疗喉鳞状细胞癌(SCC)可能会侵犯这些边界,改变肿瘤扩散的途径,从而导致潜在的复发。我们的项目目的是描述 TLM 治疗后需要全喉切除术(TL)的喉 SCC 患者的复发模式和总体生存率。

方法

从 2002 年 3 月至 2014 年 5 月在新斯科舍省哈利法克斯 QEII 健康科学中心接受 CO2 激光治疗头颈部恶性肿瘤的前瞻性 CO2 激光数据库中确定了因喉 SCC 行 TLM 治疗后需要挽救性 TL 的患者。分析手术病理报告以确定肿瘤特征、复发范围和局部结构侵犯程度。进行 Kaplan-Meier 分析以评估总体生存率、疾病特异性生存率(DSS)和局部区域控制率。

结果

从数据库中确定了 15 例因初始 TLM 切除后复发而接受挽救性 TL 的患者,这些患者均患有喉 SCC。最终病理报告显示,10/15(67%)例患者的甲状软骨受累,9/15(53%)例患者的环状软骨受累。33%(5/15)例患者有神经周围侵犯,27%(4/15)例患者有血管淋巴管侵犯。平均和中位随访时间分别为 36.7 个月和 26.8 个月(范围为 3.9-112.6 个月)。TL 后 36 个月的总体生存率的 Kaplan-Meier 估计值为 40%,标准误差(SE)为 13.6%。DSS 为 47%(SE 14.2%),TL 后局部区域控制率为 55%(SE 14.5%)。

结论

TLM 后喉复发部位似乎与已知的喉脆弱部位的历史数据一致。TLM 治疗并不会降低全喉切除和挽救性治疗后局部区域控制和总体生存率,挽救性治疗的结果与文献值一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7149/5810005/120db38e4d6e/40463_2018_266_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验